Preparation and administration of REGN-EB3 for Ebola virus disease (‎EVD)‎

Overview

Hypersensitivity reactions including infusion-associated events have been reported during and post-infusion with REGN-EB3. The most common adverse events (incidence ≥ 20%) are pyrexia, chills, tachycardia, tachypnoea and vomiting. The rate of infusion of REGN-EB3 may be slowed or interrupted if the patient develops any signs of infusion associated events.